N-Iodosuccinimide → 2-(2-Chlorophenyl)-3-(4-chlorophenyl)-7-iodomethyl-6,7-dihydro-8-oxa-1,4,8b-triaza-as-indacene

HRID 348037노트

반응식

HRID 348037 반응식
[CH2:1]([C:4]1[CH:5]=[N:6][C:7]2[N:8]([N:11]=[C:12]([C:21]3[CH:26]=[CH:25][CH:24]=[CH:23][C:22]=3[Cl:27])[C:13]=2[C:14]2[CH:19]=[CH:18][C:17]([Cl:20])=[CH:16][CH:15]=2)[C:9]=1[OH:10])[CH:2]=[CH2:3].[I:28]N1C(=O)CCC1=O>C(Cl)Cl.C(Cl)(Cl)Cl>[Cl:27][C:22]1[CH:23]=[CH:24][CH:25]=[CH:26][C:21]=1[C:12]1[C:13]([C:14]2[CH:19]=[CH:18][C:17]([Cl:20])=[CH:16][CH:15]=2)=[C:7]2[N:8]([C:9]3[O:10][CH:2]([CH2:3][I:28])[CH2:1][C:4]=3[CH:5]=[N:6]2)[N:11]=1

참가 물질

4

반응물 2

HCID 120273N-IodosuccinimideHCID 178439549HCID 178439549, 화합물

생성물 1

HCID 100069482-(2-Chlorophenyl)-3-(4-chlorophenyl)-7-iodomethyl-6,7-dihydro-8-oxa-1,4,8b-triaza-as-indacene

시약·촉매·용매 1

HCID 18399249Chloroform dichloromethane용매

실험 절차

To a mixture of 6-allyl-3-(4-chlorophenyl)-2-(2-chlorophenyl)-pyrazolo[1,5-a]pyrimidin-7-ol (I-15A-1a; 25 mg, 0.063 mmol) in 9:1 methylene chloride/chloroform (0.63 ml) at 0° C. was added N-iodosuccinimide (15 mg, 0.066 mmol), portionwise. The reaction was stirred overnight at room temperature and then extracted from water with ethyl acetate. The combined organic layers were washed with brine, dried (MgSO4), and then concentrated, in vacuo. Purification on a Biotage™ Flash 12S column using 20% ethyl acetate in hexanes as eluant afforded compound 15A-1 (15 mg, 46%) as a solid: +ESI MS (M+1) 522.3; 1H NMR (400 MHz, CD3OD) δ 8.46 (s, 1H), 7.53–7.40 (m, 6H), 7.24 (d, J=8.7 Hz, 2H), 5.45–5.41 (m, 1H), 3.81–3.64 (m, 2H), 3.33 (d, J=6.2 Hz, 2H).

후처리

  1. extractionextracted from water with ethyl acetate
  2. washThe combined organic layers were washed with brine
  3. dry with materialdried (MgSO4)
  4. concentrationconcentrated, in vacuo
  5. customPurification on a Biotage™ Flash 12S column
  6. customafforded compound 15A-1 (15 mg, 46%) as a solid

출처 및 근거

ORD 기록
ord-45c210288c4843b49c840a060e68abf2
출처 데이터셋
uspto-grants-2007_02
특허 번호
US07176210B2

반응 노트

불러오는 중…